Clinical studies of phosphodiesterase inhibitors for cardiovascular disease.
Numano
F
F
Third Department of Medicines, Tokyo Medical and Dental University, Japan.
Kishi
Y
Y
Ashikaga
T
T
D000328:Adult; D000368:Aged; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000077407:Cilostazol; D000242:Cyclic AMP / Q000097:blood; D006152:Cyclic GMP / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D010991:Plethysmography / Q000187:drug effects; D011817:Rabbits; D013777:Tetrazoles / Q000008:administration & dosage / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000242:Cyclic AMP; D006152:Cyclic GMP; D000077407:Cilostazol